Evidence map›Paper›PMID 41165910›Full record

ReviewJapanese journal of radiology2026

Predictive imaging in abdominal oncology: current trends and future directions.

Maxime Barat, Stylianos Tzedakis, Anna Pellat, Ugo Marchese, Anthony Dohan, Romain Coriat, Elliot K Fishman, Linda Chu, Philippe Soyer

Abstract readReview
PubMed Publisher
In one paragraph

Review in Japanese journal of radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Maxime BaratDepartment of Radiology, Hôpital Cochin, Assistance Publique-Hopitaux de Paris, 75014, Paris, France.ORCID http://orcid.org/0000-0002-0360-0875
Stylianos TzedakisFaculté de Médecine, Université Paris Cité, 75006, Paris, France.ORCID http://orcid.org/0000-0002-5934-0320
Anna PellatFaculté de Médecine, Université Paris Cité, 75006, Paris, France.ORCID http://orcid.org/0000-0001-6024-4830
Ugo MarcheseFaculté de Médecine, Université Paris Cité, 75006, Paris, France.ORCID http://orcid.org/0000-0002-8647-7584
Anthony DohanDepartment of Radiology, Hôpital Cochin, Assistance Publique-Hopitaux de Paris, 75014, Paris, France.ORCID http://orcid.org/0000-0002-8732-5603
Romain CoriatFaculté de Médecine, Université Paris Cité, 75006, Paris, France.ORCID http://orcid.org/0000-0003-4420-8340
Elliot K FishmanThe Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.ORCID http://orcid.org/0000-0002-2567-1658
Linda ChuThe Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.ORCID http://orcid.org/0000-0001-9729-2756
Philippe SoyerDepartment of Radiology, Hôpital Cochin, Assistance Publique-Hopitaux de Paris, 75014, Paris, France. philippe.soyer@aphp.fr.ORCID http://orcid.org/0000-0002-5055-1682

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While the concept of predictive imaging is not entirely new, advanced analytic tools such as radiomics and machine learning have laid the foundation for a new generation of predictive imaging, which goes far beyond what is visible to the human eye. Predictive imaging has emerged as a transformative tool in abdominal oncology, offering the potential to personalize cancer detection and diagnosis, staging, treatment planning, monitoring and prognostication. A growing trend in predictive imaging is the creation of integrated models that combine multimodal imaging data, clinical parameters, genomic and molecular biomarkers. These integrated models can potentially offer superior prognostic capabilities and better risk stratification than traditional models in patients with abdominal cancers. Predictive imaging powered by radiomics and delta radiomics, artificial intelligence, and multimodal data integration is on the way for reshaping abdominal oncology. When current challenges are overcome, it is presumable that predictive imaging will offer powerful, noninvasive means to guide individualized care for patients with abdominal cancers, translating imaging data into actionable clinical insights. The purpose of this article was to provide an overview of the capabilities of predictive imaging in hepatic, pancreatic, colorectal, and gastric cancers.

Indexed as

Abdominal NeoplasmsDiagnostic ImagingAbdomenHumansMedical OncologyPredictive Value of TestsArtificial intelligenceImaging biomarkersOncologic imagingPredictive imagingRadiomics

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.